United Therapeutics Corporation (UTHR)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
United Therapeutics Corporation's Days Sales Outstanding (DSO) for the years 2020, 2021, 2022, 2023, and 2024 are not available or not provided in the financial data. DSO is a measure of the average number of days it takes for a company to collect payment after a sale has been made. Without this information, it is challenging to assess the efficiency of the company in collecting receivables and managing its cash flow. It is important for stakeholders and analysts to have access to DSO data to evaluate United Therapeutics Corporation's effectiveness in managing its accounts receivable and overall liquidity position.
Peer comparison
Dec 31, 2024